Loading...
•
Sep 30, 2025
Tempus AI Inc Q3 2025 Earnings Report
Tempus AI reported strong revenue growth in Q3 2025 and achieved positive adjusted EBITDA for the first time.
Key Takeaways
Tempus AI delivered exceptional year-over-year revenue growth in Q3 2025, driven by strength in both Genomics and Data & Services. The company posted a net loss but achieved positive adjusted EBITDA, marking a key profitability milestone.
Revenue by Segment
Forward Guidance
Tempus raised its full-year 2025 revenue guidance and expects Q4 adjusted EBITDA to reach ~$20 million.
Positive Outlook
- Raised full-year 2025 revenue guidance to $1.265 billion.
- Expecting slightly positive full-year adjusted EBITDA.
- Anticipates $20 million adjusted EBITDA in Q4 2025.
- Expanded capabilities through the acquisition of Paige.
- Strong growth in oncology and hereditary testing volumes.
Challenges Ahead
- Paige acquisition expected to increase losses by ~$5 million per quarter.
- Continued GAAP net losses despite adjusted EBITDA improvement.
- Increased amortization from acquisitions impacts profitability.
- Loss on debt extinguishment added one-time costs.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...